Neural ID provides the only collaborative biosignal analytics platform spanning the pharmaceutical lifecycle. From the discovery process through clinical and health information, Neural ID delivers a scalable enterprise solution addressing the industry’s productivity crisis. Our flagship product, IWS performs machine learning, massive data reduction and delivers results with a single interoperable data format to help customers make better decisions faster, leading to increased product revenues and reduced development costs. Neural ID, based in San Carlos, CA, launched IWS in 2013. Further information is available at www.neuralid.com.